1. Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation in the Internet2 Community May 7, 2002

2. 2 FDA Organization Center for Biologics Evaluation and Research Center for Devices and Radiological Health Center for Drug Evaluation and Research Center for Food Safety and Applied Nutrition Center for Veterinary Medicine National Center for Toxicological Research Office of Regulatory Affairs Office of the Commissioner

3. 3 FDA Regulatory Science Focus Public health questions Better tools and methods New science, new technologies Information management Adeptness of scientific workforce Consumer information

4. 4 New Science - New Technologies Genomics, proteomics Tissue products Robotics Biosensors, drug delivery systems Transgenics

5. 5 Information Management Informatics Artificial intelligence tools Knowledge/ data management Computational science Risk Management

6. 6 FDA - A Scientific Agency Training, retraining Communication among scientists

7. 7 Consumer Information Freedom of choice, right to know Risk communication

8. 8 Internet2 - Current Status =Ramp-up stage, i.e., disseminate information across the agency =Facilitate communication between and among interested scientists =Identify potential uses for Internet2 technology  Identify regulatory implications =Assess value to agency